T2 Biosystems, Inc. Quarterly Costs and Expenses in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
T2 Biosystems, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2014 to Q3 2024.
  • T2 Biosystems, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $12.1M, a 19.5% decline year-over-year.
  • T2 Biosystems, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $49.3M, a 18.9% decline year-over-year.
  • T2 Biosystems, Inc. annual Costs and Expenses for 2023 was $56.9M, a 26.6% decline from 2022.
  • T2 Biosystems, Inc. annual Costs and Expenses for 2022 was $77.5M, a 9.11% increase from 2021.
  • T2 Biosystems, Inc. annual Costs and Expenses for 2021 was $71M, a 19.4% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $49.3M $12.1M -$2.93M -19.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $52.3M $11.5M -$3.49M -23.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $55.8M $14.7M -$1.1M -7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $56.9M $11M -$4.01M -26.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $60.9M $15.1M -$4.4M -22.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $65.3M $15M -$5.92M -28.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $71.2M $15.8M -$6.33M -28.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $77.5M $15M -$2.26M -13.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $79.8M $19.5M -$163K -0.83% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 $79.9M $20.9M +$3.46M +19.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $76.5M $22.1M +$5.43M +32.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $71M $17.3M +$1.15M +7.15% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $69.9M $19.6M +$3.76M +23.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $66.1M $17.5M +$6.08M +53.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 $60M $16.7M +$552K +3.43% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $59.5M $16.1M +$672K +4.35% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 $58.8M $15.9M +$1.86M +13.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $57M $11.4M -$4.2M -26.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $61.2M $16.1M +$762K +4.97% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $60.4M $15.4M +$50K +0.33% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 $60.3M $14M +$2.38M +20.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $58M $15.6M +$772K +5.21% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $57.2M $15.3M +$1.6M +11.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $55.6M $15.4M -$641K -4% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $56.2M $11.6M -$1.91M -14.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 $58.1M $14.8M -$42K -0.28% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 $58.2M $13.7M -$340K -2.41% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 $58.5M $16M +$2.21M +16% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 $56.3M $13.5M +$516K +3.96% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 $55.8M $14.9M +$567K +3.97% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 $55.2M $14.1M +$267K +1.93% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q4 2016 $55M $13.8M +$1.26M +10% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-19
Q3 2016 $53.7M $13M +$815K +6.67% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-19
Q2 2016 $52.9M $14.3M +$3.21M +28.9% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-19
Q1 2016 $49.7M $13.8M +$3.48M +33.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-19
Q4 2015 $46.2M $12.6M +$3.6M +40.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 $42.6M $12.2M +$4.43M +56.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 $38.2M $11.1M +$3.94M +55.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 $34.2M $10.3M +$3.43M +49.7% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 $30.8M $8.96M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 $7.79M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 $7.15M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 $6.91M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.